Twin Lakes Capital Management, LLC Allogene Therapeutics, Inc. Transaction History
Twin Lakes Capital Management, LLC
- $146 Million
- Q1 2024
A detailed history of Twin Lakes Capital Management, LLC transactions in Allogene Therapeutics, Inc. stock. As of the latest transaction made, Twin Lakes Capital Management, LLC holds 1,957 shares of ALLO stock, worth $4,559. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,957
Previous 1,957
-0.0%
Holding current value
$4,559
Previous $6,000
33.33%
% of portfolio
0.01%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ALLO
# of Institutions
164Shares Held
106MCall Options Held
97.5KPut Options Held
45.6K-
Tpg Gp A, LLC Fort Worth, TX18.7MShares$43.6 Million1.76% of portfolio
-
Black Rock Inc. New York, NY9.65MShares$22.5 Million0.0% of portfolio
-
State Street Corp Boston, MA9.18MShares$21.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.21MShares$19.1 Million0.0% of portfolio
-
Primecap Management CO Pasadena, CA5.45MShares$12.7 Million0.02% of portfolio
About Allogene Therapeutics, Inc.
- Ticker ALLO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 143,807,008
- Market Cap $335M
- Description
- Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult p...